MVA-BN-RSV Vaccine Trial

Clinical trial NCT05238025 · TERMINATED

Trial details

NCT number: NCT05238025
Sponsor: Bavarian Nordic
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2022-04-19
Primary completion: 2023-06-29
Enrollment: 20419

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.